Publications, Pharmaceutical

Delivering On The Promises of Intranasal Vaccination

Intranasal vaccination offers a number of valuable benefits. Nasal vaccines are easy to self-administer, non-invasive and trigger a broad immune response, notably mucosal immunity. This article reviews the advantages of intranasal vaccination, the challenges associated with developing nasal spray vaccines and recent advances in the field. COVID-19 has had a hugely disruptive impact on the vaccines market. Although only four nasal spray vaccines are currently in commercial use a significant number of intranasal spray vaccines for COVID-19 are in development, holding out the promise of adding mucosal immunity to improve resistance to the virus. The design of the drug delivery technology and emerging strategies for successful vaccine formulation are discussed.

For more information on ONdrugDelivery.

Download Publication
Author(s): Dr. Julie Suman Nektaria Karavas
18 Nov 2021

This Might Also Be of Interest

5 Dec 2024

Optimising Preclinical Studies for Intranasal and Pulmonary Programmes

Publications, Pharmaceutical, Market Insights, Product Solutions, Device Innovations

Read More
27 Nov 2024

Targeted Aerosol Delivery to NALT Using BiVax Intranasal Atomizer

Publications, Pharmaceutical, Device Innovations, Market Insights, Product Solutions

Read More
12 Nov 2024

PureHale® & The Future of Fine Mist Dispensers for Upper Airway Treatments

Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
28 Oct 2024

Acute Migraine Relief: Nose-to-Brain Delivery with Lipid Nanoparticles

Publications, Pharmaceutical, Device Innovations, Market Insights, Product Solutions

Read More
1 2 3 27
Back To Top